Peanut Skins as a Natural Antimicrobial Feed Additive to Reduce the Transmission of Salmonella in Poultry Meat Produced for Human Consumption

Salmonella is the leading cause of bacterial foodborne zoonoses in humans. Thus, the development of strategies to control bacterial pathogens in poultry is essential. Peanut skins, a considerable waste by-product of the peanut industry is discarded and of little economic value. However, peanut skins contain polyphenolic compounds identified that have antimicrobial properties. Hence, we aim to investigate the use of peanut skins as an antibacterial feed additive in the diets of broilers to prevent the proliferation of Salmonella Enteritidis (SE). One hundred sixty male hatchlings (Ross 308) were randomly assigned to, (1) PS: peanut skin diet without SE inoculation (2) PSSE: peanut skin diet and SE inoculation 3) CON: control diet without SE inoculation (4) CONSE: control diet with SE inoculation. Feed intake and body weights were determined at week 0 and 5. On days 10 and 24 post hatch, 3 birds/pen (24 total) from each treatment group were euthanized and the liver, spleen, small intestine, and ceca were collected. The weights of the liver, spleen and ceca were recorded. Organ invasion was determined by counting SE colonies. Each pen served as an experimental unit and was analyzed using a t-test. Performance data was analyzed in a completely randomized design using a general linear mixed model to evaluate differences. There were no significant differences ( P > 0.05) in weekly average pen body weight, total feed consumption, bird weight gain and feed conversion ratio between the treatment groups. There were no significant differences in SE CFU/g for fecal, litter or feed between treatment groups CONSE and PSSE. However, for both fecal and litter, the PSSE treatment group tended (P ≤0.1) to have a lower Salmonella CFU/g compared to the CONSE treatment group. The results indicate that peanut skins may have potential application as an antimicrobial feed additive to reduce the transmission or proliferation of SE in poultry environments or flocks.

334 Effect of Dietary Supplementation of Peanut Skins with and Without Polyphenols on the Performance, Rumen Fermentation and Carcass Characteristics of Florida-native Sheep

The objective of this study was to evaluate the effects of dietary supplementation of peanut skins (PS) with and without polyphenols on the performance, rumen fermentation, and carcass characteristics of Florida-Native Sheep. Thirty-three intact lambs were randomly blocked by body weight (BW) (33.5 ± 0.1 kg; 11 lambs per treatment) and distributed in three isonitrogenous (17.1%) and isocaloric (2.5 Mcal/kg) diets: 1) Control diet, 2) Diet + 20% of intact peanut skins (IPS) and, 3) Diet + 20% of treated PS without polyphenols (TPS) for 42 d + 7 days of adaptation. Then, lambs were slaughtered to evaluate carcass characteristics and rumen fermentation. Dry matter intake (DMI), BW, and blood samples were collected and analyzed using the effects of treatment, week, interactions, and the random effect of animals. Dietary IPS and TPS did not (P > 0.05) affect DMI (1.14, 1.15 vs 1.04 kg/d) and final BW (35.9, 35.8 vs 36.8 kg) compared to the control. Dietary TPS reduced (P < 0.01) blood glucose levels compared to IPS and control (67.9 vs 74.6, 75.7 mg/dL) but IPS had lower (P = 0.03) blood urea nitrogen than TPS and control (5.79 vs 6.0, 6.32 mmol/L). Both IPS and TPS decreased (P < 0.01) total volatile fatty acid concentration (37.9, 14.2 vs 45.8 mmol/L) and increased rumen pH (7.1, 6.9 vs 6.7) compared to the control. Carcass weight was similar between treatments, TPS reduced (P = 0.01) dressing percentage compared to IPS and control (42.6 vs 45.2, 46.6%), both IPS and TPS reduced liver weight compared to control (230, 223 vs 302 g). Conversely, IPS and TPS increased (P < 0.01) alpha-tocopherol concentration (3.73, 4.0 vs 1.24 mg/g) in lean meat compared to control. This study showed that IPS increased the incorporation of antioxidants in meat without affecting animal performance.

The Effect of Feeding Hens a Peanut Skin-Containing Diet on Hen Performance, and Shell Egg Quality and Lipid Chemistry

Peanut skins are a considerable waste product with little current economic value or use. We aimed to determine the dietary effects of peanut skins on layer production performance and egg quality and chemistry of the eggs produced. Two hundred commercial hens were randomly assigned to four treatments (five replicates) and fed ad libitum for 8 weeks: conventional control diet, diet containing 24% high-oleic peanut (HOPN), diet containing 3% peanut skin (PN Skin), and a diet with 2.5% oleic acid (OA). Hens fed the HOPN diet had significantly reduced body weights relative to the control and PN Skin treatments, producing fewer total eggs over the 8-week experimental period. Eggs weights were similar between the control and PN Skin treatments at weeks 2 and 4, while eggs from the PN Skin treatment group were heavier than other treatments at weeks 6 and 8 of the experiment. Eggs produced from the HOPN treatment had reduced saturated fatty acid (FA) content in comparison to the other treatment groups, while similar between PN Skin and control eggs at week 8 of the experiment. This study suggests that PN skins may be a suitable alternative layer feed ingredient.

Phytochemicals as Potential Inhibitors of Advanced Glycation End Products: Health Aspects and Patent Survey

Background: Glycation is a chemical reaction that synthesize advanced glycation endproducts (AGEs). The AGEs irreversibly damage macromolecules present in tissues and organs, leading to the impairment of biological functions. For instance, the accumulation of AGEs induces oxidative stress and consequently inflammatory responses in human body, leading to the on set/worsening of diseases, including obesity, asthma, cognitive impairment, and cancer. There is a current demand on natural and low-cost sources of antiglycant agents. As a result, food phytochemicals presented promising results to inhibit glycation and consequently, the formation of AGEs. Objective: Here, we describe the mechanism of glycation on the worsening of diseases, the methods os detection, and the current findings on the use of phytochemicals (phenolic compounds, phytosterols, carotenoids, terpenes and vitamins) as natural therapeuticals to inhibit health damages via inhibition of AGEs in vitro and in vivo. Methods: This manuscript reviewed publications available in the PubMed and Science Direct databases dated from the last 20 years on the uses of phytochemicals to inhibit the AGEs in vitro and in vivo. Also, recent patents on the use of anti-glycant drugs were reviewed using the Google Advanced Patents database. Results and Discussion: Phenolic compounds have been mostly studied to inhibit AGEs. Food phytochemicals derived from agroindustry wastes, including peanut skins, and the bagasses derived from citrus and grapes are promising antiglycant agents via scavenging of free radicals, metal ions, the suppression of metabolic pathways that induces inflammation, the activation of pathways that promote antioxidant defense, the blocking of AGE connection with the receptor for advanced glycation endproducts (RAGE). Conclusion: Phytochemicals derived from agroindustry are promising anti-glycants, which can be included to replace synthetic drugs for AGE inhibition, and consequently to act as a therapeutical strategy to prevent and treat diseases caused by AGEs, including diabetes, ovarian cancer, osteoporosis, and Alzheimer’s disease.

Phytochemicals from peanut (Arachis hypogaea L.) skin extract with potential for pharmacological activity

Background: Plant phenolics, commonly present in legumes, leafy vegetables, fruits, grains are a key source of bioactive nutrients existing as flavonols, flavanones, flavanols, phytosterols, among others. Peanuts, being crops of high commercial use, undergo processing that generates voluminous agro-wastes. The waste comprises both the shells and skins, which could be valorized. Its versatile functionality has encouraged extensive research into peanut skin-derived chemicals for diverse applications over the past few decades. Peanut skin, however, is ascertained to be rich in flavonoids, stilbenes (resveratrol), and other phenolic compounds. Methods: This review presents the biologically active compounds and pharmacological activities of peanut skins and their related works over the past few years. Articles carefully chosen from broad databases such as Scopus, Science Direct, Pub Med, SciFinder, among others, were used as the primary data. Results: The bioactive components of peanut skin extracts exhibit anti-oxidant, anti-inflammatory, anti-bacterial, anti-viral, anti-fungal, anti-cancer/anti-tumour, anti-cardiovascular, and anti-diabetes/obesity activities via in vitro and in vivo models. Besides, their varied biological properties make them potential precursors for the management of diverse diseases and ailments. Potential applications: Phytochemicals from peanut skins could be deployed as an antioxidant, antidiabetic and antimicrobial agents in drugs for the clinical treatment of ailments with extensive clinical applications. Conclusion: The present review covers the chemistry and pharmacological activities of peanut skin phytochemicals. Our findings in this review substantiate the importance of peanut skin extracts and their varied potential for the treatment of specific diseases. The results indicate that they are attractive target compounds for the development of new drugs. We hope that this information will inform further in vivo studies on the role of peanut skin phenolic compounds in our health.

Extracts of Peanut Skins as a Source of Bioactive Compounds: Methodology and Applications

Peanut skins are a waste product of the peanut processing industry with little commercial value. They are also significant sources of the polyphenolic compounds that are noted for their bioactivity. The extraction procedures for these compounds range from simple single solvent extracts to sophisticated separation schemes to isolate and identify the large range of compounds present. To take advantage of the bioactivities attributed to the polyphenols present, a range of products both edible and nonedible containing peanut skin extracts have been developed. This review presents the range of studies to date that are dedicated to extracting these compounds from peanut skins and their various applications.